Exceptional Response to Nivolumab and Stereotactic Body Radiation Therapy (SBRT) in Neuroendocrine Cervical Carcinoma with High Tumor Mutational Burden: Management Considerations from the Center For Personalized Cancer Therapy at UC San Diego Moores Cancer Center

Neuroendocrine carcinoma of the cervix is an ultra‐rare malignancy with a poor prognosis and limited treatment options. Checkpoint blockade immunotherapy has rapidly developed into an emerging standard of care for several common disease types. Interestingly, in preclinical and retrospective clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharabi, Andrew, Kim, Sangwoo Shawn, Kato, Shumei, Sanders, Philip D., Patel, Sandip Pravin, Sanghvi, Parag, Weihe, Elizabeth, Kurzrock, Razelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2017
Materias:
Precision Medicine Clinic
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469598/
https://www.ncbi.nlm.nih.gov/pubmed/28550027
http://dx.doi.org/10.1634/theoncologist.2016-0517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469598/
https://www.ncbi.nlm.nih.gov/pubmed/28550027
http://dx.doi.org/10.1634/theoncologist.2016-0517

Ejemplares similares